Our CEO Andreas Nilsson will have a presentation about the underlying benefits of compression at the 18th European Venous Forum Meeting in Porto, Portugal.
PressCise AB was during three days working with Dr. Prof. Hugo Partsch and Dr. Prof. Giovanni Mosti in Lucca, Italy. A clinical trial was performed with the aim to investigate the differences in increase of ejection fraction on patients with venous insufficiency, by the use of PressCise elastic compression bandages and PressPatch™, the newest device with high stiffness. The method used was strain gauge plethysmography.
Today you can read about PressCise is BT (Borås newspaper) and why we decided to move to Herrljunga recently.
Read the article here.
PressCise has visit two important fairs this month. ITMA in Milan, Italy is the worlds largest trade show for textile machinery and MEDICA in Düsseldorf, Germany, which is one of the leading health care fairs in Europe.
This week we are welcoming Katarina Lindström, our new Product & Quality manager. Katarina is a textile engineer with a background from apparel production. We also inaugurate our new office at the station house, in Herrljunga.
From left to right: Bengt Olander, Chairman of the Board, Josefin Damm, CEO and Katarina Lindstöm, Product & Quality manager.
Today PressCise moved out from the Incubator in Borås, after three whole years. We want to thank the Incubator for the support, positivism and belief in our ideas! The CEO Josefin Damm together with the business coach Markus Bredberg, and the CEO Henrik Jansson from the Incubator.
In May, 2014 a comparative study to Keller et.al 2009, was performed with PressCise, showing that 21 nurses with different working experience all where able to achieve the target pressure using PressCise. ”The results shows that for each 95 % confidence intervals, independent of state and position, we get at most 5 mmHg from the target pressure 50 mmHg”
The article by Wiklander et.al. “Investigation of the ability to provide a defined ‘target pressure’ with the use of the compression bandage PressCise” is published at the website of International Wound Care. To download the article follow this link or contact us.
During a whole year, the co-founder and inventor professor Torbjörn Lundh is guest professor at Stanford University in California. To get to the university's web page click here.
Photo by Ragnhild Larsson @ Konvoj Production.
The ICC conferens, organised by the International Compression Club, was held in Bari, Italy this year. The CEO Josefin Damm, represented PressCise AB and presented the PressCise™ bandage and the new invention PressPatch. The products gained a lot of positive response, both from the clinicians and the industry, and several dialogues was initiated and will continue the following weeks.
To read more about the ICC, follow the link here.
PressCise visited the well-renowned and experienced professor in dermatology, Dr. Hugo Partsch in Vienna, to test our newest invention PressPatch™.
A new patent application was filed, concerning a complementary product to PressCise™.
Dr. Lars Peterson, the well-renowned professor in orthopaedics, is now performing user studies with PressCise™ together with players from Gothenburg's oldest football (soccer) team Örgryte IS.
Dr. Peterson is a professor of Orthopaedic Surgery at the University of Goteborg with a long experience in treating athletes. He has served as head physician of the Swedish National Team in ice hockey and football, is a former member of the Sports Medical Committee of FIFA, a founding member of FIFA's Medical Assessment and Research Center, has served as a Medical Officer at six World Cups in Football, been President of the Swedish Society of Sports Medicine and he was President and one of the founding members of the International Society of Cartilage Repair (ICRS). He has also published several books in the fields of Orthopaedic Surgery, Sports Traumatology and Sports Medicine, Biomechanics and Rehabilitation.
During August, PressCise™ AB also received a product development order from a large medical device company.
During the summer a share issue was conducted with existing and new owners in order to raise money for market introduction and the members of our Advisory board was elected as full members of our Board of directors.
We received our CE-mark for the bandage, initiated dialogues with several potential distributors for different segments, filed two patents, three researchers submitted an article on our bandage that will be published later this year, Swedish football teams started using our bandage and the bandage was presented at a Nordic horse research conference at the Swedish University of Agricultural Sciences.
© PressCise AB - edited June 2017